Beyond The Script
Beyond The Script
Podcast Description
Exploring the science, stories, and breakthroughs shaping the future of medical cannabis. Brought to you by releaf.co.uk
Podcast Insights
Content Themes
The podcast focuses on various aspects of medical cannabis, including leadership in healthcare, the importance of data in transitioning from anecdotal evidence to real-world outcomes, and market expansion strategies. Episodes cover themes like purpose-driven leadership in medical practices, advancements in research, and the challenges within the UK's medical cannabis framework, with examples including discussions on high-performance healthcare leadership and moving towards evidence-based practices.

Exploring the science, stories, and breakthroughs shaping the future of medical cannabis. Brought to you by releaf.co.uk
“We didn’t set up a cannabis clinic. We set up a healthcare clinic that used cannabis as a medication.”
That distinction is everything; in this episode of Beyond the Script, Releaf’s CEO Tim Kirby explains what he saw in a broken market, how he built the team and culture behind the UK’s largest medical cannabis clinic, and what the job is really about.
Tim talks about entering a space dominated by people who thought medical cannabis was a political cause, not a healthcare solution, and why that gap was the entire opportunity. He also gets into what leadership actually looks like from the inside, what he hopes every Releaf employee gets to experience one day, and why he believes the culture you have is the culture you deserve.

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.